Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Teva
Fish and Richardson
Express Scripts
Cerilliant
UBS
Federal Trade Commission
Baxter
Argus Health

Generated: November 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020325

« Back to Dashboard

NDA 020325 describes PEPCID AC, which is a drug marketed by J And J Consumer Inc and is included in three NDAs. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the PEPCID AC profile page.

The generic ingredient in PEPCID AC is famotidine. There are eighteen drug master file entries for this compound. One hundred and fourteen suppliers are listed for this compound. Additional details are available on the famotidine profile page.
Summary for 020325
Tradename:PEPCID AC
Applicant:J And J Consumer Inc
Ingredient:famotidine
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 020325
Suppliers and Packaging for NDA: 020325
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PEPCID AC famotidine TABLET;ORAL 020325 NDA Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division 16837-855 16837-855-05 1 BLISTER PACK in 1 CARTON (16837-855-05) > 5 TABLET, FILM COATED in 1 BLISTER PACK
PEPCID AC famotidine TABLET;ORAL 020325 NDA Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division 16837-855 16837-855-09 1 BOTTLE, PLASTIC in 1 PACKAGE (16837-855-09) > 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength10MG
Approval Date:Apr 28, 1995TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength20MG
Approval Date:Sep 23, 2003TE:RLD:Yes

Expired US Patents for NDA 020325

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
J And J Consumer Inc PEPCID AC famotidine TABLET;ORAL 020325-001 Apr 28, 1995 ➤ Sign Up ➤ Sign Up
J And J Consumer Inc PEPCID AC famotidine TABLET;ORAL 020325-001 Apr 28, 1995 ➤ Sign Up ➤ Sign Up
J And J Consumer Inc PEPCID AC famotidine TABLET;ORAL 020325-001 Apr 28, 1995 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Chinese Patent Office
UBS
Teva
Cipla
Queensland Health
US Army
Argus Health
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.